Life Sciences 360
by Harsh Thakkar
Latest episode
Why Every Medical Affairs Team Needs Their Own AI Agent in 2025
Why Every Medical Affairs Team Needs Their Own AI Agent in 2025
About this podcast
Life Sciences 360 is an interview show that educates anyone on challenges, trends, and insights in the life-sciences industry. Hosted by Harsh Thakkar, a life-sciences industry veteran and CEO and co-founder of Qualtivate, the show features subject-matter experts, business leaders, and key life-science partners contributing to bringing new therapies to patients worldwide. Harsh is passionate about advancements in life sciences and tech and is always eager to learn from his guests— making the show both informative and useful.
Episodes
The newest 20 of 86 episodes
- Why Every Medical Affairs Team Needs Their Own AI Agent in 2025 · 49 min · Season 4 Episode 86Medical misinformation, life sciences burnout, and AI-powered content creation collide in this episode with Dr. Ome Ogbru, founder & CEO of AINGENS and creator of MACg (Medical…
- VC Money Tight? Here’s How Startups Still Land Top Talent (2025) · 47 min · Season 4 Episode 85What happens when 3,500 staffers lose their jobs due to FDA layoffs, venture capital (VC) term sheets shrink, and AI drug-discovery startups raise $600 million rounds? Executive…
- Why Most Healthcare Brands Fail (And How to Fix It) · 51 min · Season 3 Episode 84Why Most Healthcare Brands Fail (And How to Fix It) In this episode, Holley Miller, Founder and President of Grey Matter Marketing, reveals why most medtech and life sciences…
- 4.5 Billion Molecules, One Mission: Cure the ‘Undruggable’ Diseases · 31 min · Season 3 Episode 83Solving the “Undruggable” Disease Problem with Goldilocks Molecules In this episode, Christian Schafmeister, Founder and President of Third Law Molecular, reveals a new class of…
- What Separates Life Science Startup Winners from Losers? · 39 min · Season 3 Episode 82Why Startups Fail (Hint: It’s Not the Innovation) In this episode, Carlo Odicino, CEO and Founder at One TEAM Partners, shares the real reasons why most early-stage life sciences…
- Pandora's Box of Secrets EXPOSED in Drug Pricing Transparency! · 30 min · Season 3 Episode 81The Hidden Math Behind Drug Pricing: Why Patients Pay More Than They Should In this episode, Michael Grosberg, VP of Product Management at Model N, breaks down the complex drug…
- A CCO’s Brutally Honest Advice if You Want to Succeed in Pharma Commercialization · 32 min · Season 3 Episode 80Early Commercialization Strategies That Actually Work (Especially for Startups!) In this episode, John Harlow, Chief Commercial Officer at Melinta Therapeutics, shares real-world…
- Digital Health Expert: THIS is the No.1 Roadblock to Healthcare AI Adoption · 35 min · Season 3 Episode 79Healthcare AI adoption is transforming the way we address risk, confidentiality, and patient care. In this episode, RJ Kedziora, co-founder of Estenda Solutions talks about the…
- Tired of Supply Chain Errors? Here’s the Fix: Drug Serialization for DSCSA Compliance · 40 min · Season 3 Episode 78Drug serialization is at the heart of modern pharmaceutical supply chain security. In this episode Michael Rowe, Senior Director of DSCSA and Serialization Services at TwoLabs…
- Why Equitable Healthcare is the KEY to Better Health · 22 min · Season 3 Episode 77Equitable healthcare is the key to bridging health gaps and creating better patient outcomes. In this episode, Amy West, Principal, Advisory Services at HitLab, share her…
- Can AI Help Doctors Find Cancer Faster? · 37 min · Season 3 Episode 76Have you ever wondered if AI could help doctors find cancer faster and more accurately? In this episode, we explore OmniScreen, an AI-powered biomarker tool that is…
- Why Science Marketing Will Make Your Company EXPLODE in 2025? · 44 min · Season 3 Episode 75Have you ever wondered why marketing in the life sciences industry is so different from traditional marketing? In this episode, we dive deep into the power of science marketing…
- Why Most New Drugs Don't Launch: The Hidden Challenges in Pharma · 38 min · Season 3 Episode 74Have you ever wondered why so many new drugs fail even after years of research and billions in investment? In this episode, we dive deep into the challenges of drug…
- Why 55% of Clinical Trials Fail – The Truth About Drug Development · 44 min · Season 3 Episode 73Have you ever wondered why so many clinical trials fail before reaching the market? In this episode, we dive deep into the hidden challenges of clinical trials with Rob…
- How to Get Quick Access to GLP-1 Medications without Health Insurance ft. Dr. Jonathan Kaplan · 41 min · Episode 72In this episode of Life Sciences 360, we dive deep into the world of GLP-1 medications with Dr. Jonathan Kaplan. We discuss weight management, how these medications work, their…
- Astellas Pharma’s Approach to Cell and Gene Therapy · 36 min · Episode 71In this episode of LifeSciences 360, we dive into the fascinating world of cell and gene therapy manufacturing with Carlos Yuraszeck. With over 16 years of experience, Carlos…
- ISPE’s Role in Shaping the Future of mRNA and Personalized Medicine · 34 min · Episode 70In this episode of Life Sciences 360, we dive into the evolution of pharmaceutical and biotech manufacturing with our guest, Scott, a seasoned expert with nearly 30 years of…
- Balancing Leadership Roles in a High-Stakes Industry with Taggart McGurrin · 30 min · Episode 69Welcome to another episode of Life Sciences 360! Today, we're diving into the intricate world of life sciences leadership with a special guest who's worn nearly every hat in the…
- Why Antimicrobial Resistance Is the Biggest Challenge in Public Health · 41 min · Episode 68In this episode of Life Sciences 360, host Harsh Thakkar sits down with Marc Sheetz, Associate Dean of Research at Midwestern University's College of Pharmacy, to discuss the…
- The Secret to Better Medications: Standardizing Pharmacogenomics (PGx) Testing · 30 min · Episode 67Imagine knowing how your body will respond to a medication before you even take it! In this episode, Harsh Thakkar interviews Sarah Rogers, co-founder and president of the…
